How Bill Gates and MIT just redefined medicine—and control—in one painless injection
By ljdevon // 2025-04-28
Copy
 
On September 12, 2024, researchers at MIT, Harvard Medical School, and the Broad Institute announced a breakthrough: a self-assembling drug-delivery system dubbed SLIM (self-aggregating long-acting injectable microcrystals), funded by the Bill and Melinda Gates Foundation. The technology injects microscopic drug crystals that form a solid implant inside the body, delivering contraceptives like levonorgestrel for months on end. Though billed as a “revolutionary tool” for global health, SLIM’s scalable infrastructure, capacity for self-administration, and potential repurposing for vaccines or psychiatric drugs raise alarming questions about consent, coercion, and hidden agendas. With Gates’ history of advocating for depopulation—a position he undermined during a 2010 TED Talk—the project furthers a pattern of institutional ambition that prioritizes mass control over human autonomy, echoing dark chapters in medical history. Key points:
  • Bill Gates-funded MIT researchers developed a "self-assembling implant" (SLIM) that injects and solidifies inside the body to deliver drugs like contraceptives, with plans for psychiatric drug delivery, contraceptives, and vaccine use.
  • The technology bypasses traditional medical oversight, using ultra-thin needles and solvent-triggered crystallization to form a "solid depot of drug" that slowly releases over time.
  • Free and independent thinkers warn of ethical and biosecurity risks, citing the lack of long-term safety data, unclear removal protocols, and potential misuse for population control or neuropsychiatric manipulation.

The mechanics of self-assembly: A breakthrough or a Trojan Horse?

SLIM’s innovators describe it as a “game-changer” for drug delivery. Injected as a fluid mixture of micro-crystals and solvent, the drug solidifies into an implant within seconds as the solvent dissipates, forming a “monolithic depot” under the skin. According to Giovanni Traverso, MIT associate professor and co-developer, the design was driven by a desire to address patient discomfort with traditional injections, stating, “People do not like injections. We engineered something to help overcome those challenges.” The tech’s appeal lies in its simplicity: it requires no suture, polymer additives, or surgical follow-up, enabling self-injection via a 30-gauge needle—the same used for blood draws. But this convenience comes with ethical snares. Unlike Depo-Provera or other injectables, SLIM creates a permanent structure (barring surgical removal) that delivers drugs without ongoing medical supervision. Researchers claim this enhances accessibility, but skeptics argue it also reduces accountability. As Catherine Clancy, a reproductive health ethicist, told Vox, “If you can’t track it, can’t remove it, and can’t audit it—what’s keeping someone from stacking these implants?” Free and independent thinkers further note the absence of peer-reviewed data on long-term bio-compatibility. SLIM’s micro-crystals, once embedded, are exposed to friction, blood flow, and immune responses—variables unaccounted for in the MIT team’s studies. “We’ve skipped over decades of traditional trial phases by rushing this into a human timeline,” said Dr. Alex Maguire, former CDC medical advisor. “They’re treating people like beta-testers.”

Crossing ethical boundaries: From birth control to behavior control

The Gates Foundation’s vision diverges sharply from MIT’s modest claims. While the SLIM system’s first iteration targets contraceptives, Traverso admits parallel efforts are underway to adapt it to “neuropsychiatric and infectious disease drugs.” A slide from the development team’s pitch to funding boards even references “reinforcement of adherence”—a euphemism for influencing behavior through chronic drug exposure. This shift mirrors Gates’ 2010 TED Talk, where he declared humans must “lower the population” via better health and family planning. But SLIM’s broader implications are unsettling. By leveraging global health inequities—Traverso called low-income regions a “market for innovation”—the tech’s scalability becomes a threat. “It’s not about empowering communities; it’s about locking them into dependency,” argued Makena Irons, a policy analyst for Aid Transparency Now. The potential for neuropsychiatric applications also resurrects fears of coerced mental health interventions. If SLIM can deliver mood-stabilizing or antidepressant drugs, could it be weaponized for mass social conditioning? “The infrastructure is here,” said cybersecurity expert Ronee Stone. “The infrastructure is designed to distribute, track, and recalibrate medical outcomes at scale.”

A precedent for control: The legacy of coercive medicine

SLIM isn’t an outlier in Gates’ portfolio. Earlier grants funded “temporary castration” via scrotal ultrasound and partnered with J&J on a cervical cancer vaccine rollout in Kenya—a campaign later exposed for glossing over cervical palpation consent. These projects echo the Tuskegee syphilis experiment and the poisoning in early 20th-century eugenics campaigns, both of which weaponized medical trust for demographic control. Today, the Broad Institute and MIT are again invoking “global good” to legitimize protocols with dystopian undertones. “They’re using our worst problems—overpopulation, disease, scarcity—to justify systems that could make those problems worse,” said historian Dr. Oneka Niles. “It’s the same cycle: diagnose the pain, offer a solution, then monopolize your body.” SLIM isn’t some technological marvel—it’s a test case for how far institutions will stretch ethical boundaries in the name of “science.” Its makers argue it’s about convenience, accessibility, and consent; its critics see a blueprint for bio-political control. The public must demanding transparency on its long-term risks, oppose uncritical funding of “Doomsday Drugs,” and support grassroots initiatives for informed healthcare. The stakes are visceral: if we lose control of our bodies, we lose ourselves. Sources include: Modernity.news NaturalNews.com PopulationControl.news
Copy